Stay updated on KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.

Latest updates to the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page has updated contact information for several locations and research centers, including changes in phone numbers and addresses, as well as the removal of outdated dates and recruitment statuses.SummaryDifference2%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe webpage has updated key contact information and locations for clinical research sites, including new phone numbers and addresses, while removing outdated details. Notably, the site names have changed from 'Vertex Research Group' to 'Vertex Clinical Research, LLC' and the status of recruitment has been updated.SummaryDifference4%
- Check40 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.7%
- Check48 days agoChange DetectedThe Floridian Neuroscience Institute in Miami has updated its contact information and personnel, with new sites and phone numbers added, while the previous entries have been removed, indicating a significant update in their recruiting status and site management.SummaryDifference5%
- Check62 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check69 days agoChange DetectedNew research sites and contact information have been added, including multiple locations in California and Florida, as well as hospitals in China, while several previous entries have been removed, including some sites and contact numbers from Miami and Zhejiang.SummaryDifference13%
Stay in the know with updates to KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.